By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmaMar S.A. 

Pol Ind. la Mina Avenida de los Reyes, 1

Colmenar Viejo  Madrid  28770  Spain
Phone: 34-91-8466000 Fax: 34-91-8466001


Company News
PharmaMar Starts A Quadruple Combination Study With Aplidin For The Treatment Of Multiple Myeloma 8/9/2017 12:07:02 PM
FDA Chooses Zepsyre (PM1183) From PharmaMar To Explore Potential Development For Pediatric Cancers 6/20/2017 7:40:52 AM
PharmaMar Will Commercialize PM1183 With The Trade Name Of Zepsyre 6/16/2017 9:42:26 AM
PharmaMar And Eczacibasi Sign A Licensing Agreement For Aplidin In Turkey 5/25/2017 9:16:22 AM
PharmaMar Announces New Data With Its Compounds Yondelis And Lurbinectedin During ASCO 2017 5/19/2017 9:02:55 AM
PharmaMar: Sylentis Announces New Preclinical And Clinical Data For Its SYL1001 Molecule During Association for Research in Vision & Ophthalmology 2017 5/9/2017 8:06:55 AM
PharmaMar: Aplidin Receives Orphan Drug Status For The Treatment Of Multiple Myeloma In Switzerland 5/4/2017 8:18:49 AM
PharmaMar Demonstrates Its Progress In R&D In New York 4/28/2017 11:21:49 AM
PharmaMar Presents New Data On The Treatment Of Multiple Myeloma And Ovarian Cancer At The AACR Congress 4/4/2017 10:34:16 AM
PharmaMar, Chugai Pharma Ink Anticancer Drug Pact; PharmaMar to Receive Upfront $31.33 Million (30 Million Euros) 12/22/2016 6:32:20 AM